Dr. Markus Stein
   Dr. Markus Stein

Assistant Professor, Department of Medical Microbiology, College of Medicine, University of Manitoba
Director, Clinical Microbiology Fellowship Training Program, College of Medicine, University of Manitoba
Clinical Microbiologist, Diagnostic Services of Manitoba

Degrees: M.Sc. [Microbiology] (Tübingen, Germany, 1993), Ph.D. [Microbiology] (Tübingen, Germany, 1997)

Postdoctoral Fellowship: Novartis (Siena, Italy, 2002), Provincial Laboratory for Public Health (Edmonton, 2011)

Professional Certifications/Awarded Fellowships: D[ABMM] (2013), F[CCM] (2013)

Mailing Address: Department of Clinical Microbiology, Health Sciences Centre, MS673C – 820 Sherbrook Street, Winnipeg, MB, R3A 1R9

Tel: (204) 787 4597  Fax: (204) 787 4699 
E-mail: mstein2@dsmanitoba.ca

Research Interests:
Antimicrobial resistance; diagnostic clinical microbiology; virulence of Helicobacter pylori

For a list of PubMed articles, click here.

Recent Publications:

Mishra JP, Cohen D, Zamperone A, Nesic D, Muesch A, and Stein M. 2015. CagA of Helicobacter pylori interacts with and inhibits the Serine-Threonine Kinase PRK2. Cellular Microbiology. Nov; 17(11):1670-82

Mishra J, Ruggiero P., Bagnoli F., Rappuoli R., and Stein M.; 2015. Helicobacter pylori: The cancer bug (Chapter 10); © Springer International Publishing Switzerland 2015; M.R. Shurin et al. (eds.), Infection and Cancer: Bi-Directorial Interactions, DOI 10.1007/978-3-319-20669-1

Stein M (2014) CagA, A Master Regulator of Host Protein Phosphorylation Events. SOJ Microbiol Infect Dis 2(1): 2. http://dx.doi.org/10.15226/sojmid.2013.00108

Stein M, Ruggiero P, Rappuoli R, Bagnoli F. 2013. Helicobacter pylori CagA: from pathogenic mechanisms to its use as an anti-cancer vaccine. Front. Immunol. - Immunotherapies and Vaccines, Volume 4|Article328|